DRUG · Mapped RxNorm record
Simvastatin
Normalized identity: simvastatinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis
NCT00242268
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Relapsing Remitting Multiple Sclerosisunresolved
Interventions
SimvastatinDRUG · verified · RxNorm: simvastatin
Sponsors & collaborators
Alabama Neurology Associates, PClead sponsor
Biogencollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00242268 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.